Cargando…
Pulmonary arterial hypertension: the case for a bioelectronic treatment
Pulmonary arterial hypertension (PAH) is a rare disease of unknown etiology that progresses to right ventricular failure. It has a complex pathophysiology, which involves an imbalance between vasoconstrictive and vasodilative processes in the pulmonary circulation, pulmonary vasoconstriction, vascul...
Autores principales: | Ntiloudi, Despοina, Qanud, Khaled, Tomaio, Jacquelyn-Nicole, Giannakoulas, George, Al-Abed, Yousef, Zanos, Stavros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098229/ https://www.ncbi.nlm.nih.gov/pubmed/32232109 http://dx.doi.org/10.1186/s42234-019-0036-9 |
Ejemplares similares
-
The Fifth Bioelectronic Medicine Summit: today’s tools, tomorrow’s therapies
por: Chang, Eric H., et al.
Publicado: (2023) -
Haemodynamic effects of initial combination therapy in pulmonary arterial hypertension: a systematic review and meta-analysis
por: Farmakis, Ioannis T., et al.
Publicado: (2022) -
Anodal block permits directional vagus nerve stimulation
por: Ahmed, Umair, et al.
Publicado: (2020) -
Organ- and function-specific anatomical organization of vagal fibers supports fascicular vagus nerve stimulation
por: Jayaprakash, Naveen, et al.
Publicado: (2023) -
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension
por: Farmakis, Ioannis T., et al.
Publicado: (2023)